Vitamin B12 (Cyanocobalamin)

What Is Cyanocobalamin?

Cyanocobalamin is the cyanide-bearing form of vitamin B12, a cobalt-containing molecule that humans must obtain from food. Plants, fungi, animals and humans do not synthesize vitamin B12; only prokaryotes do^[1].

Vitamin B12 was historically called the anti-pernicious anemia factor. Four forms are used commercially in foods and medicines: cyanocobalamin, hydroxocobalamin, 5′-deoxyadenosylcobalamin and methylcobalamin^[2]. Cyanocobalamin itself is not a cofactor. Cells remove its cyanide ligand and convert the cobalamin core into the two active coenzyme forms^[3].

Vitamin B12 behaves differently from most B-complex vitamins: it is more stable, has a highly specific absorption mechanism, and is stored in large amounts in the body^[1]. Research on cyanocobalamin covers its coordination chemistry, stability, absorption and the consequences of deficiency.

Chemical Structure and Molecular Identity

Cyanocobalamin is a cobalt(III) complex built on a corrin ring, with a 5,6-dimethylbenzimidazole nucleotide as the lower axial ligand and a cyanide ion as the upper axial ligand. PubChem (CID 5311498) lists the molecular formula C63H88CoN14O14P and a molecular weight of 1355.4 g/mol. The CAS number is 68-19-9.

The corrin macrocycle holds the cobalt ion through four nitrogen atoms. A 2023 review of cobalt corrinoid chemistry emphasizes how the corrin ligand controls and modifies the properties of the metal, including its axial ligand substitution, redox chemistry and photochemistry^[4]. The different B12 forms are distinguished by the upper axial ligand: cyanide in cyanocobalamin, hydroxide in hydroxocobalamin, a methyl group in methylcobalamin and a 5′-deoxyadenosyl group in adenosylcobalamin^[2].

Stability and analytical identification

Stability varies among the forms. A 2022 review compared their reactivity under temperature, pH and light, and in the presence of oxidants, reductants and other water-soluble vitamins, and summarized published data on the content-related quality of B12 products^[2]. Cyanocobalamin is generally regarded as the most robust of the four, which is one reason it is widely used in fortified foods and medicines.

In the laboratory, cyanocobalamin is a dark red crystalline solid with characteristic visible-UV absorption maxima near 361 and 550 nm. Pharmacopeial identity tests use absorbance ratios at these wavelengths, and HPLC with UV detection or LC-MS separates cyanocobalamin from hydroxocobalamin and other corrinoid impurities.

Research History and Development

Vitamin B12 research began with the search for the factor that corrected pernicious anemia and expanded into absorption physiology, coordination chemistry and enzymology. Absorption depends on intrinsic factor, a gastric protein that was the subject of a 1964 review in the New England Journal of Medicine^[5].

Reviews from the 1970s and 1980s covered vitamin B12 nutrition and the clinical chemistry of its measurement^[6][7]. A 2005 review in Chemical Reviews addressed the chemistry and enzymology of vitamin B12^[8], and coordination chemists continue to refine models of corrinoid ligand substitution and redox behavior, increasingly with density functional theory calculations^[4].

Later work focused on how cobalamin is processed inside cells. The complex structure and dual cofactor forms of cobalamin require a multistep series of absorptive and processing events before it can serve as an enzyme cofactor^[3]. Studies of the cblC (MMACHC) processing protein have used cells with disrupted cblC as a model of functional cobalamin deficiency^[9].

Mechanisms Studied in Research

Vitamin B12 is required for two enzymatic reactions in humans: the conversion of L-methylmalonyl-CoA to succinyl-CoA, and the methylation of homocysteine to methionine. Cyanocobalamin contributes to both only after conversion into the appropriate cofactor form^[1].

• Methylmalonyl-CoA mutase uses adenosylcobalamin in mitochondria. It is required for the catabolism of certain branched-chain amino acids into an anaplerotic substrate, and its failure disrupts mitochondrial energy metabolism^[3].
• Methionine synthase uses methylcobalamin to remethylate homocysteine to methionine, producing S-adenosylmethionine, the main cellular methyl donor. The reaction uses 5-methyltetrahydrofolate as the one-carbon donor, linking B12 to folate metabolism and to thymidylate and purine synthesis^[3].

Because these reactions consume methylmalonyl-CoA and homocysteine, B12 deficiency raises methylmalonic acid and homocysteine, which serve as diagnostic biomarkers^[9]. Absorption is mediated by intrinsic factor, and a 2007 review notes that this system saturates at physiologic intakes, so the fraction absorbed falls as the amount per meal rises^[10].

Key Findings From Published Studies

Published findings on vitamin B12 center on bioavailability, deficiency biomarkers, intracellular processing defects and associations with neuropathy.

Bioavailability and dietary sources

The main dietary sources of vitamin B12 are meat, milk and dairy products, fish, shellfish and eggs, which is why vegetarians are considered at risk of deficiency^[1]. A 2007 review reported that average B12 bioavailability in healthy humans was 42% from fish, 56% to 89% from sheep meat and 61% to 66% from chicken, while B12 in eggs appeared poorly absorbed (under 9%)^[10]. Most edible blue-green algae contain predominantly pseudovitamin B12, which is inactive in humans, whereas fortified breakfast cereals were identified as a valuable source for vegans and older adults^[10].

Cell models of processing defects

In cultured cells with cblC (MMACHC) mutations, proteomic changes involved the cytoskeleton, neurological proteins and signaling and detoxification pathways. Adding hydroxocobalamin to these cells failed to restore the normal phenotype, suggesting that a defective processing pathway produces irreversible changes at the protein level^[9].

Human observational and trial data

A 2021 systematic review and meta-analysis of 46 observational and 7 interventional studies found that peripheral neuropathy was associated with lower B12 levels and higher methylmalonic acid and homocysteine. B12 treatment showed a non-significant association with symptom improvement across four studies, and the authors noted that most trials did not assess vitamin status before treatment^[11].

Measurement itself has limits. A 2026 position paper from the European Federation of Clinical Chemistry and Laboratory Medicine on recreational nitrous oxide use identified plasma homocysteine and methylmalonic acid as the central diagnostic markers and cautioned that serum B12 results may be falsely reassuring, often falling in the low-normal range^[12].

Because cobalamin forms differ only in one axial ligand, researchers typically verify cyanocobalamin identity and purity with HPLC and mass spectrometry certificates of analysis.

Because cobalamin forms differ only in one axial ligand, researchers typically verify cyanocobalamin identity and purity with HPLC and mass spectrometry certificates of analysis.

Regulatory and Research Status

Cyanocobalamin is an FDA-approved drug, available by prescription for the treatment of vitamin B12 deficiency, including deficiency caused by pernicious anemia. It is also widely used in food fortification.

A 2025 review describes the full range of current topics, from structure, stability and pharmacokinetics to the diagnosis of deficiency, analytical methods for measuring B12, and potential toxicity^[1]. Quality remains an active research question: the 2022 stability review summarized published data on the B12 content of products on the market and evaluated stabilization approaches for manufacturing and storage^[2].

Open research questions include how intracellular processing defects cause lasting cellular changes^[9] and whether B12 status should be measured before treatment in neuropathy trials^[11].